[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Dudaniec et al., 2021 - Google Patents

Generation of Epstein-Barr virus antigen-specific T cell receptors recognizing immunodominant epitopes of LMP1, LMP2A, and EBNA3C for immunotherapy

Dudaniec et al., 2021

Document ID
16807548425798583693
Author
Dudaniec K
Westendorf K
Nössner E
Uckert W
Publication year
Publication venue
Human Gene Therapy

External Links

Snippet

Epstein-Barr virus (EBV) infections in healthy individuals are usually cleared by immune cells, wherein CD8+ T lymphocytes play the most important role. However, in some immunocompromised individuals, EBV infections can lead to the development of cancer in …
Continue reading at www.liebertpub.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector

Similar Documents

Publication Publication Date Title
JP6612963B2 (en) Compositions and methods for using recombinant T cell receptors to directly recognize tumor antigens
CN102272153B (en) High affinity t cell receptor and use thereof
JP7328211B2 (en) TCRs and peptides
Gerdemann et al. Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma
Alter et al. NK cells in HIV‐1 infection: evidence for their role in the control of HIV‐1 infection
Kedzierska et al. The ABC of major histocompatibility complexes and T cell receptors in health and disease
Dudaniec et al. Generation of Epstein-Barr virus antigen-specific T cell receptors recognizing immunodominant epitopes of LMP1, LMP2A, and EBNA3C for immunotherapy
WO2016095783A1 (en) T cell receptor for identifying eb virus short peptide
KR20170137118A (en) T cell receptor
Schaft et al. T cell re-targeting to EBV antigens following TCR gene transfer: CD28-containing receptors mediate enhanced antigen-specific IFNγ production
Sundarasetty et al. Lentivirus-induced dendritic cells for immunization against high-risk WT1+ acute myeloid leukemia
US20220119477A1 (en) Tcr and peptides
WO2007109583A2 (en) Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject
AU2019240370B2 (en) Genetically reprogrammed Tregs expressing membrane-bound IL-10
Lorenz et al. Unbiased identification of T-cell receptors targeting immunodominant peptide–MHC complexes for T-cell receptor immunotherapy
Landmeier et al. Activated human γδ T cells as stimulators of specific CD8+ T-cell responses to subdominant epstein barr virus epitopes: potential for immunotherapy of cancer
WO2023133540A1 (en) Il-12 affinity variants
Thomas et al. Strong and sustained effector function of memory‐versus naïve‐derived T cells upon T‐cell receptor RNA transfer: Implications for cellular therapy
Gupta et al. EBV LMP1, a viral mimic of CD40, activates dendritic cells and functions as a molecular adjuvant when incorporated into an HIV vaccine
Weigand et al. Isolation of human MHC class II‐restricted T cell receptors from the autologous T‐cell repertoire with potent anti‐leukaemic reactivity
Mangino et al. Presentation of native TROP‐2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen‐presenting cells
Ma et al. Next Generation Sequencing‐Based Identification of T‐Cell Receptors for Immunotherapy Against Hepatocellular Carcinoma
Yang et al. Evaluation of Epstein‐Barr Virus Latent Membrane Protein 2 Specific T‐Cell Receptors Driven by T‐Cell Specific Promoters Using Lentiviral Vector
US20240009235A1 (en) T cell receptors directed against bob1 and uses thereof
US20250057881A1 (en) Compositions and methods for use of recombinant t cell receptors against claudin 6